Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Name: Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer
Published: 2020
License: Public Domain

Mayo Clinic · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

anatomic stage i breast cancer ajcc v8, anatomic stage ii breast cancer ajcc v8, anatomic stage iii breast cancer ajcc v8, breast ductal carcinoma in situ, breast fibrocystic change, breast lobular carcinoma in situ, invasive breast carcinoma, prognostic stage i breast cancer ajcc v8, prognostic stage ia breast cancer ajcc v8, prognostic stage ib breast cancer ajcc v8, prognostic stage ii breast cancer ajcc v8, prognostic stage iia breast cancer ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 876680
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.